NICOLE GUERRERO: Open Payments
NPI 1558490383 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173 in 9 payments from 7 companies in 2025. Trend: 2023 $126 · 2024 $340 · 2025 $173
Food & beverage: $173
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Organon LLC | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Celltrion USA Inc. | 1 | $14 |
Products named: DUPIXENT, XIFAXAN, VOQUEZNA, RENFLEXIS, VELSIPITY, MAVYRET, VEGZELMA, CREON.
Industry payments across MO — which companies pay providers there.
